132 related articles for article (PubMed ID: 2263875)
1. Protective effect of S-adenosyl-L-methionine in hepatic uroporphyria. Evaluation in an experimental model.
Cantoni L; Budillon G; Cuomo R; Rodinò S; Le Grazie C; Di Padova C; Rizzardini M
Scand J Gastroenterol; 1990 Oct; 25(10):1034-40. PubMed ID: 2263875
[TBL] [Abstract][Full Text] [Related]
2. Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria.
von Tiepermann R; Koss G; Doss M
Hoppe Seylers Z Physiol Chem; 1980 Aug; 361(8):1217-22. PubMed ID: 7409755
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene].
Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC
Acta Physiol Pharmacol Latinoam; 1987; 37(4):541-54. PubMed ID: 3274026
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
[TBL] [Abstract][Full Text] [Related]
5. Bile and biliary lipid secretion in rats with hexachlorobenzene-induced porphyria. Effect of S-adenosyl-L-methionine administration.
Cuomo R; Rodino S; Rizzoli R; Simoni P; Roda E; Cantoni L; Rizzardini M; De Rosa G; Le Grazie C; Di Padova C
J Hepatol; 1991 Jan; 12(1):87-93. PubMed ID: 2007778
[TBL] [Abstract][Full Text] [Related]
6. Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls.
Smith AG; Francis JE; Green JA; Greig JB; Wolf CR; Manson MM
Biochem Pharmacol; 1990 Nov; 40(9):2059-68. PubMed ID: 2173599
[TBL] [Abstract][Full Text] [Related]
7. Heme metabolism after discontinued hexachlorobenzene administration in rats: possible irreversible changes and biomarker for hexachlorobenzene persistence.
De Catabbi SCB ; Aldonatti C; de Viale LC
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Sep; 127(2):165-75. PubMed ID: 11083027
[TBL] [Abstract][Full Text] [Related]
8. [Study of the origin of urinary porphyrins in experimental hexachlorobenzene-induced porphyria ].
Adzharov D
Biull Eksp Biol Med; 1990 Apr; 109(4):355-7. PubMed ID: 2386827
[TBL] [Abstract][Full Text] [Related]
9. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Felsher BF; Carpio NM; Engleking DW; Nunn AT
N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
[TBL] [Abstract][Full Text] [Related]
10. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria.
Smith AG; Francis JE; Dinsdale D; Manson MM; Cabral JR
Carcinogenesis; 1985 Apr; 6(4):631-6. PubMed ID: 3986965
[TBL] [Abstract][Full Text] [Related]
11. The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice.
Hahn ME; Gasiewicz TA; Linko P; Goldstein JA
Biochem J; 1988 Aug; 254(1):245-54. PubMed ID: 2845946
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Franklin MR; Phillips JD; Kushner JP
Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
[TBL] [Abstract][Full Text] [Related]
13. Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.
Doss M; Schermuly E; Koss G
Ann Clin Res; 1976; 8 Suppl 17():171-81. PubMed ID: 1008488
[TBL] [Abstract][Full Text] [Related]
14. Development of an experimental model for the study of hexachlorobenzene-induced hepatic porphyria in the rat.
Krishnan K; Brodeur J; Charbonneau M
Fundam Appl Toxicol; 1991 Oct; 17(3):433-41. PubMed ID: 1794647
[TBL] [Abstract][Full Text] [Related]
15. Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine.
Battle AM; Stella AM; De Kaminsky AR; Kaminsky C; Mariano HG
Br J Dermatol; 1987 Mar; 116(3):407-15. PubMed ID: 3567077
[TBL] [Abstract][Full Text] [Related]
16. [Animal experiment model of the effect of ultraviolet irradiation on hexachlorobenzene-induced porphyria].
Lehmann P; Schäfer T; Bolsen K; Goerz G
Derm Beruf Umwelt; 1990; 38(5):148-9, 151-4. PubMed ID: 2286159
[TBL] [Abstract][Full Text] [Related]
17. Uroporphyria produced in mice by iron and 5-aminolevulinic acid.
Deam S; Elder GH
Biochem Pharmacol; 1991 Jun; 41(12):2019-22. PubMed ID: 2039550
[TBL] [Abstract][Full Text] [Related]
18. Investigations on the role of free radical processes in hexachlorobenzene-induced porphyria in mice.
Rizzardini M; Graziani A; Carugo C; Cantoni L
J Biochem Toxicol; 1988; 3():33-45. PubMed ID: 3236339
[TBL] [Abstract][Full Text] [Related]
19. The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage.
Ríos de Molina MC; Mazzetti MB; Galigniana M; Aldonatti C; Tomio JM; San Martín de Viale LC
Braz J Med Biol Res; 2002 Nov; 35(11):1273-83. PubMed ID: 12426626
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
Adjarov DG; Elder GH
IARC Sci Publ; 1986; (77):467-9. PubMed ID: 3596742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
